1. Home
  2. VERV
  3. VERV News

Latest Verve Therapeutics Inc. (VERV) News on January 19, 2025

Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
VERV

GlobeNewswire

6 days ago

Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones

Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
VERV

GlobeNewswire

11 days ago

Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

16 days ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In?
VERV

Insider Monkey

20 days ago

Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In?

Verve Therapeutics, Inc. (VERV): Is This Gene Therapy Stock a Good Buy Right Now?
VERV

Insider Monkey

21 days ago

Verve Therapeutics, Inc. (VERV): Is This Gene Therapy Stock a Good Buy Right Now?

Verve Therapeutics Slides As Insider Purchases Lose Another US$65k
VERV

Simply Wall St.

a month ago

Verve Therapeutics Slides As Insider Purchases Lose Another US$65k

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

2 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

VERV

MT Newswires

2 months ago

RBC Capital Adjusts Price Target on Verve Therapeutics to $17 From $20, Maintains Outperform, Speculative Risk Rating

Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations
VERV

Simply Wall St.

2 months ago

Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
VERV

Zacks

2 months ago

Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates

VERV

Associated Press Finance

2 months ago

Verve Therapeutics: Q3 Earnings Snapshot

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
VERV

GlobeNewswire

2 months ago

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

3 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

State Street Corp's Strategic Acquisition in Verve Therapeutics
VERV

GuruFocus.com

3 months ago

State Street Corp's Strategic Acquisition in Verve Therapeutics

Is Verve Therapeutics, Inc. (VERV) the Best NASDAQ Stock Under $5?
VERV

Insider Monkey

4 months ago

Is Verve Therapeutics, Inc. (VERV) the Best NASDAQ Stock Under $5?

Jim Cramer on Vertiv Holdings (VRT): ‘I Think It’s A Winner’
VERV

Insider Monkey

4 months ago

Jim Cramer on Vertiv Holdings (VRT): ‘I Think It’s A Winner’

Millennium Management LLC's Strategic Acquisition in Verve Therapeutics Inc
VERV

GuruFocus.com

4 months ago

Millennium Management LLC's Strategic Acquisition in Verve Therapeutics Inc

Verve Therapeutics, Inc. (VERV): Among the Worst ARK Stocks According to Short Sellers
VERV

Insider Monkey

4 months ago

Verve Therapeutics, Inc. (VERV): Among the Worst ARK Stocks According to Short Sellers

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

5 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

VERV

MT Newswires

5 months ago

RBC Capital Adjusts Price Target on Verve Therapeutics to $20 From $25, Maintains Outperform Rating

Verve Therapeutics (VERV) Reports Q2 Loss, Lags Revenue Estimates
VERV

Zacks

5 months ago

Verve Therapeutics (VERV) Reports Q2 Loss, Lags Revenue Estimates

VERV

Associated Press Finance

5 months ago

Verve Therapeutics: Q2 Earnings Snapshot

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
VERV

GlobeNewswire

5 months ago

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

6 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

We're Not Very Worried About Verve Therapeutics' (NASDAQ:VERV) Cash Burn Rate
VERV

Simply Wall St.

6 months ago

We're Not Very Worried About Verve Therapeutics' (NASDAQ:VERV) Cash Burn Rate

VERV

MT Newswires

6 months ago

RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk

Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now?
VERV

Insider Monkey

6 months ago

Why Is Verve Therapeutics, Inc. (VERV) the Most Shorted Stock Loved by Analysts Now?

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

7 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
VERV

GlobeNewswire

7 months ago

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

One Verve Therapeutics Insider Raised Stake By 29% In Previous Year
VERV

Simply Wall St.

7 months ago

One Verve Therapeutics Insider Raised Stake By 29% In Previous Year

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

8 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

VERV

MT Newswires

8 months ago

Verve Therapeutics Names Troy Lister Chief Scientific Officer

Verve Therapeutics Announces Leadership Update
VERV

GlobeNewswire

8 months ago

Verve Therapeutics Announces Leadership Update

Verve Therapeutics to Participate in Upcoming Investor Conferences
VERV

GlobeNewswire

8 months ago

Verve Therapeutics to Participate in Upcoming Investor Conferences

VERV

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 05/16/2024

Verve Therapeutics, Inc. (NASDAQ:VERV) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
VERV

Simply Wall St.

8 months ago

Verve Therapeutics, Inc. (NASDAQ:VERV) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Analysts Are Betting On Verve Therapeutics, Inc. (NASDAQ:VERV) With A Big Upgrade This Week
VERV

Simply Wall St.

8 months ago

Analysts Are Betting On Verve Therapeutics, Inc. (NASDAQ:VERV) With A Big Upgrade This Week

Verve Therapeutics First Quarter 2024 Earnings: Beats Expectations
VERV

Simply Wall St.

8 months ago

Verve Therapeutics First Quarter 2024 Earnings: Beats Expectations

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
VERV

Zacks

8 months ago

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

VERV

Associated Press Finance

8 months ago

Verve Therapeutics: Q1 Earnings Snapshot

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
VERV

GlobeNewswire

8 months ago

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

Verve moves forward with backup base editing therapy
VERV

BioPharma Dive

8 months ago

Verve moves forward with backup base editing therapy

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
VERV

GlobeNewswire

8 months ago

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

9 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
VERV

Zacks

9 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

After a Serious Setback, Is Verve Therapeutics a Buy?
VERV

Motley Fool

9 months ago

After a Serious Setback, Is Verve Therapeutics a Buy?

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
VERV

Zacks

9 months ago

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
VERV

Zacks

10 months ago

Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls

Verve Plunges To Record Low After Cholesterol-Lowering Gene Editor Causes Side Effects
VERV

Investor's Business Daily

10 months ago

Verve Plunges To Record Low After Cholesterol-Lowering Gene Editor Causes Side Effects

Verve Falls as Gene-Editing Trial Paused on Safety Issues
VERV

Bloomberg

10 months ago

Verve Falls as Gene-Editing Trial Paused on Safety Issues

Verve Plummets To Record Low After Its Gene-Editing Drug Causes Side Effects
VERV

Investor's Business Daily

10 months ago

Verve Plummets To Record Low After Its Gene-Editing Drug Causes Side Effects

VERV

Reuters

10 months ago

UPDATE 1-Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels

VERV

Reuters

10 months ago

Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels

Verve Therapeutics Announces Updates on its PCSK9 Program
VERV

GlobeNewswire

10 months ago

Verve Therapeutics Announces Updates on its PCSK9 Program

Verve pauses base editing trial, shifts strategy after treatment side effect
VERV

BioPharma Dive

10 months ago

Verve pauses base editing trial, shifts strategy after treatment side effect

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

10 months ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VERV

GlobeNewswire

a year ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

New Forecasts: Here's What Analysts Think The Future Holds For Verve Therapeutics, Inc. (NASDAQ:VERV)
VERV

Simply Wall St.

a year ago

New Forecasts: Here's What Analysts Think The Future Holds For Verve Therapeutics, Inc. (NASDAQ:VERV)

Verve Therapeutics Full Year 2023 Earnings: Beats Expectations
VERV

Simply Wall St.

a year ago

Verve Therapeutics Full Year 2023 Earnings: Beats Expectations

VERV

GuruFocus.com

a year ago

Verve Therapeutics Inc (VERV) Reports Progress and Financials for Q4 and Full Year 2023

VERV

Associated Press Finance

a year ago

Verve Therapeutics: Q4 Earnings Snapshot

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
VERV

GlobeNewswire

a year ago

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
VERV

InvestorPlace

a year ago

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential

Relay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last?
VERV

Zacks

a year ago

Relay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last?

3 Gene Editing Stocks With Unprecedented Surge Potential
VERV

InvestorPlace

a year ago

3 Gene Editing Stocks With Unprecedented Surge Potential

2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
VERV

Motley Fool

a year ago

2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
VERV

GlobeNewswire

a year ago

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential
VERV

InvestorPlace

a year ago

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential

VERV

Associated Press Finance

a year ago

Merchants Bancorp: Q4 Earnings Snapshot

Coeur Reports Record 2023 Fourth Quarter Production at its Newly Expanded Rochester Operation and Provides Update on First Half 2024 Crusher Commissioning and Ramp-Up Progress
VERV

Business Wire

a year ago

Coeur Reports Record 2023 Fourth Quarter Production at its Newly Expanded Rochester Operation and Provides Update on First Half 2024 Crusher Commissioning and Ramp-Up Progress

Merchants Bancorp Reports Fourth Quarter 2023 Results
VERV

PR Newswire

a year ago

Merchants Bancorp Reports Fourth Quarter 2023 Results

New Strong Buy Stocks for January 29th
VERV

Zacks

a year ago

New Strong Buy Stocks for January 29th

Verve Therapeutics, Inc. (NASDAQ:VERV) is a favorite amongst institutional investors who own 64%
VERV

Simply Wall St.

a year ago

Verve Therapeutics, Inc. (NASDAQ:VERV) is a favorite amongst institutional investors who own 64%

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.
VERV

Motley Fool

a year ago

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

ZipRecruiter to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
VERV

Business Wire

a year ago

ZipRecruiter to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

Sallie Mae (SLM) Lags Q4 Earnings Estimates
VERV

Zacks

a year ago

Sallie Mae (SLM) Lags Q4 Earnings Estimates

Strength Seen in Zuora (ZUO): Can Its 6.1% Jump Turn into More Strength?
VERV

Zacks

a year ago

Strength Seen in Zuora (ZUO): Can Its 6.1% Jump Turn into More Strength?

Factors Setting the Tone for Malibu Boats' (MBUU) Q2 Earnings
VERV

Zacks

a year ago

Factors Setting the Tone for Malibu Boats' (MBUU) Q2 Earnings

11 Stocks That Will Make You Rich in 5-10 Years
VERV

Insider Monkey

a year ago

11 Stocks That Will Make You Rich in 5-10 Years

VERV

Reuters

a year ago

UPDATE 1-Kaman to be taken private by Arcline Investment Management in $1.8 bln deal

VERV

Reuters

a year ago

Kaman to be bought by Arcline Investment Management in $1.8 billion deal

VERV

Business Wire

a year ago

Kaman to be Acquired by Arcline for $1.8 Billion

Sonic Automotive Schedules Release of 2023 Fourth Quarter and Full Year Financial Results
VERV

Business Wire

a year ago

Sonic Automotive Schedules Release of 2023 Fourth Quarter and Full Year Financial Results

7 Mighty Healthcare Stocks Changing the Game of Medicine
VERV

InvestorPlace

a year ago

7 Mighty Healthcare Stocks Changing the Game of Medicine

First Majestic Produces 6.6 Million AgEq Oz in Q4 2023 and 26.9 Million AgEq Oz in 2023; Announces 2024 Production and Cost Guidance and Conference Call Details
VERV

Newsfile

a year ago

First Majestic Produces 6.6 Million AgEq Oz in Q4 2023 and 26.9 Million AgEq Oz in 2023; Announces 2024 Production and Cost Guidance and Conference Call Details

RLJ Lodging Trust Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
VERV

Business Wire

a year ago

RLJ Lodging Trust Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

NW Natural Holdings Schedules Earnings Release and Conference Call for Friday, February 23
VERV

Business Wire

a year ago

NW Natural Holdings Schedules Earnings Release and Conference Call for Friday, February 23

3 Stocks to Buy in the Booming Field of Gene Editing
VERV

InvestorPlace

a year ago

3 Stocks to Buy in the Booming Field of Gene Editing

Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024
VERV

Business Wire

a year ago

Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024

Why Fisker Stock Continued to Plunge Today
VERV

Motley Fool

a year ago

Why Fisker Stock Continued to Plunge Today

Analysts Agree These 8 Cathie Wood Stock Picks Will Soar In 2024
VERV

Investor's Business Daily

a year ago

Analysts Agree These 8 Cathie Wood Stock Picks Will Soar In 2024

Is Kaman Corporation (NYSE:KAMN) Trading At A 20% Discount?
VERV

Simply Wall St.

a year ago

Is Kaman Corporation (NYSE:KAMN) Trading At A 20% Discount?

Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
VERV

GlobeNewswire

a year ago

Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Verve Therapeutics (VERV) Moves to Buy: Rationale Behind the Upgrade
VERV

Zacks

a year ago

Verve Therapeutics (VERV) Moves to Buy: Rationale Behind the Upgrade

Wall Street Analysts Think Verve Therapeutics (VERV) Could Surge 217.73%: Read This Before Placing a Bet
VERV

Zacks

a year ago

Wall Street Analysts Think Verve Therapeutics (VERV) Could Surge 217.73%: Read This Before Placing a Bet

VERV

Business Wire

a year ago

Douglas Emmett Announces Dates for Its 2023 Fourth Quarter Earnings Results and Live Conference Call

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession
VERV

GlobeNewswire

a year ago

MAG Announces the Appointment of Tom Peregoodoff to the Board of Directors as Part of Planned Board Succession

Dentsply Sirona Declares Quarterly Cash Dividend
VERV

GlobeNewswire

a year ago

Dentsply Sirona Declares Quarterly Cash Dividend

Is MiMedx Group, Inc. (NASDAQ:MDXG) Trading At A 50% Discount?
VERV

Simply Wall St.

a year ago

Is MiMedx Group, Inc. (NASDAQ:MDXG) Trading At A 50% Discount?

VERV

Business Wire

a year ago

Douglas Emmett Declares Quarterly Cash Dividend

Share on Social Networks: